stockrowC4 Therapeutics, Inc. (CCCC) vs Surrozen, Inc. (SRZN)
- C4 Therapeutics, Inc. CCCC 2.79 −3.46%
- Surrozen, Inc. SRZN 31.66 −0.69%
C4 Therapeutics, Inc. and Surrozen, Inc. are both Biotechnology companies. Surrozen, Inc. is the larger, with a market value of $607.7M against $379.5M — 1.6× the size. C4 Therapeutics, Inc. grew revenue faster over the last twelve months: 7.20% against −8.79%. C4 Therapeutics, Inc. has the higher net margin (−282.2% vs −2,887.1%) and the lower return on invested capital (−279.8% vs 0.00%). Across the 14 metrics below, C4 Therapeutics, Inc. leads on 10 and Surrozen, Inc. on 4.
Valuation
Profitability
| Metric | CCCC | SRZN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.81% |
| Operating margin | (315.86%) | (385.28%) | 0.00% |
| Net margin | (282.22%) | (2,887.07%) | 0.00% |
| Free cash flow margin | (247.05%) | (303.92%) | 0.00% |
| Return on equity | (47.62%) | 387.44% | (50.30%) |
| Return on assets | (30.50%) | (304.47%) | (45.47%) |
| Return on invested capital | (279.83%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack